Latest News, Grants & Research Reports
Read our latest news, blog posts and research updates right here
Why We Run: Stories from Team Neuroblastoma
We've been truly inspired by our runners this year, especially with five incredible individuals representing Team Neuroblastoma UK in the TCS London Marathon.
As the 2025 marathon draws nearer, we caught up with two of our runners to hear about the daily routines that keep them motivated, the inspirations behind their journey, and ultimately - what drives them to run for our cause.
BBC Lifeline Appeal
We are honored to announce that Neuroblastoma UK will be featured on the BBC Lifeline Appeal on Sunday, 26 January, at 13.50 on BBC One.
Neuroblastoma UK Awards £1.1 Million in 2024 Grant Round
Neuroblastoma UK is awarding £1.1 million in its 2024 grant round to fund new innovative research into neuroblastoma. New therapeutic approaches, pathways to improve existing treatments and exploration of an MRNA vaccine are just some of the projects to be funded in the 2024 grant round; with an emphasis on translational research which can be rapidly transferred from the lab bench to bedside.
Charities come together for Teenage and Young Adult Cancer Awareness Month this April
This April marks the second Teenage and Young Adult Cancer Awareness Month, an opportunity for charities and the young people we support to come together and raise awareness of the unique challenges facing this age group when faced with the three words that change their lives: “you have cancer”.
6th Neuroblastoma UK Research Symposium focuses on the biology of neuroblastoma, aiming for more effective and less toxic treatments for children
It was sold out two months in advance, so it was no surprise to see a packed auditorium at Selwyn College Cambridge for the 6th Neuroblastoma UK Research Symposium on 21st and 22nd March 2024. Over 130 scientists and clinicians attended from across Europe, US, and further afield, including world leading experts in pre-clinical and clinical neuroblastoma research.
Encouraging results from the study investigating the role of Enhancer of Zeste homolog 2 (EZH2) and Natural Killer cells in Neuroblastoma
In 2023, Dr Gao, working with Prof Juliet Gray and Dr Zoë Walters at the University of Southampton, aimed to determine the role of natural killer cell- mediated anti-tumour effects in neuroblastoma, after treatment with EZH2. The objectives of the study were to look at the correlation between EZH2 protein expression and the surface expression of natural killer ligands in neuroblastoma cells, and to determine if the natural killer cells induced cytotoxicity that could be enhanced in the neuroblastoma cell lines with EZH2 inhibitors.
Thank you for your support in 2023
Thank you for supporting Neuroblastoma UK in 2023.
As we draw closer to the end of a busy but exciting year, all of us at Neuroblastoma UK would like to thank you for your support in the fight against childhood cancer. Here are some of our highlights from the year.
Big donations for the Big Give Christmas Challenge
For the first time, Neuroblastoma UK took part in the Big Give Christmas Challenge 2023. We raised a grand total to £8,602 in just seven days.
We were blown away by everyone’s support, thank you. The money raised from the Big Give Christmas Challenge will enable scientists to take crucial first steps on the road of discovery - and help get closer to a cure for neuroblastoma.
Childhood cancer survivor fronts Christmas fundraising campaign
Six year old Apollinia celebrates one year in remission as she fronts Neuroblastoma UK’s campaign to raise £8,000 for neuroblastoma research
This November, Apple celebrates one year in remission as she fronts Neuroblastoma UK’s first matched-funding campaign with the Big Give Christmas Challenge!
Celebrities Alan Carr and Scott Mills double the magic for Big Give Christmas Challenge
Press release: 15 November
Celebrity Patrons of children’s charity Neuroblastoma UK call on the public to help raise £8,000 and accelerate research into neuroblastoma, a rare childhood cancer.